Latest Pharma Topics

505(b)(2) vs. ANDA | Choosing the Right FDA Pathway for Drug Approval
Navigating the U.S. regulatory landscape requires a clear understanding of approval pathways, especially when deciding between 505(b)(2) New Drug Applications (NDA) and Abbreviated New Drug Applications (ANDA). While both are … Read More